For those who were not in Menlo Park, here is the program:
MITCNC Energy and Cleantech Series
How Biotech is Changing the Energy Industry
John Melo – CEO, Amyris
Jonathan Wolfson - CEO, Solazyme
Bob Mayer – CEO, Cobalt Technologies
Noubar Afeyan – Chairman, LS9
Don Keller – Partner, Orrick Herrington & Sutcliffe
May 8, 2012
Orrick, Herrington & Sutcliffe LLP
1000 Marsh Rd
Menlo Park, CA 95025
John Melo is CEO of Amyris. Before that, he was president of US Fuels for BP Plc, where built up its ethanol blending business. He serves on the board of Kior and US Venture and previously served ass a director at Ernst & Young in San Jose.
Jonathan Wolfson is CEO and co-founder of Solazyme. He previously served as co-founder and COO of InvestorTree. He is a director of the Clean Economy Network and the Biotechnology Industry Organization. He holds a JD and MBA from NYU.
Bob Mayer is CEO and chairman Cobalt Technologies. His experience in biotechnology includes president of Genencor International and Danisco USA. He holds a ScD in Chemical Engineering from MIT, and was an assistant professor in MIT’s chemical engineering department.
Noubar Afeyan is managing partner and CEO of Flagship Ventures, and is co-founder and chairman of three biofuels companies: LS9, Joule and Midori. He holds a PhD in Chemical Engineering from MIT and serves as a Senior Lecturer at the Sloan School.
Moderator Don Keller is a partner at Orrick, Herrington & Sutcliffe LLP, where he is one of the firm’s 11-member board of director and has advised clients on more than 60 IPOs. He holds a JD from Boston College Law School and serves on its Board of Overseers.
Emcee Joel West is a professor at the Keck Graduate Institute of Applied Life Sciences, one of the Claremont Colleges. He holds a PhD from UC Irvine and a SB from MIT.